{
    "title": "Glaxo: AI will be a game-changer for medicine",
    "url": "https://www.dailymail.co.uk/money/markets/article-12400081/Glaxo-AI-game-changer-medicine.html",
    "date": "2023-08-12",
    "keywords": [
        "ai",
        "drug",
        "technology",
        "gsk",
        "time",
        "money",
        "share",
        "account",
        "fund",
        "use",
        "development",
        "world",
        "process",
        "treatment",
        "trial",
        "disease",
        "industry",
        "risk",
        "investment",
        "fee",
        "intelligence",
        "thick",
        "fast",
        "range",
        "industriesbut",
        "cuttingedge",
        "game",
        "moment",
        "sector",
        "firmsglaxosmithkline",
        "popularity",
        "chatgpt",
        "turn",
        "effectiveness",
        "drugsthrough",
        "network",
        "hubs",
        "cross",
        "station",
        "trialsmost",
        "beginning",
        "cancer",
        "glaxosmithkline",
        "recruitment",
        "part",
        "procedure",
        "fasterai",
        "medicine",
        "example",
        "hepatitis",
        "cure",
        "year",
        "patient",
        "success",
        "lab",
        "root",
        "microsoft",
        "alphabet",
        "post",
        "revolution",
        "software",
        "salesforce",
        "article",
        "diy",
        "branson",
        "head",
        "mail",
        "discovery",
        "research",
        "timewe",
        "response",
        "firm",
        "pharma",
        "london",
        "flu",
        "aim",
        "illness",
        "executive",
        "jeremy",
        "skillington",
        "biotech",
        "biology",
        "chemistry",
        "biologyhe",
        "cost",
        "ratio",
        "medicinesthe",
        "economy",
        "britain",
        "life",
        "science",
        "superpower",
        "hub",
        "developmentit",
        "hope",
        "uk",
        "status",
        "centre",
        "creation",
        "acclaim"
    ],
    "category": [
        "money",
        "markets"
    ]
}